In addition, group 1 ILC inhibit the proliferation of CD8+ T cells by affecting the availability of IL-2 in long-term interaction with CD8+ T cells, which may be another target for inhibiting liver fibrosis 201. The gene discussed is CD8A; the disease is Hepatic fibrosis.